Literature DB >> 26871868

An Improved Molecular Histology Method for Ion Suppression Monitoring and Quantification of Phosphatidyl Cholines During MALDI MSI Lipidomics Analyses.

Laure Jadoul1, Nicolas Smargiasso1, Fabien Pamelard2, Deborah Alberts1, Agnès Noël3, Edwin De Pauw1, Rémi Longuespée1,4.   

Abstract

Tissue lipidomics is one of the latest omics approaches for biomarker discovery in pharmacology, pathology, and the life sciences at large. In this context, matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) is the most versatile tool to map compounds within tissue sections. However, ion suppression events occurring during MALDI MSI analyses make it impossible to use this method for quantitative investigations without additional validation steps. This is especially true for lipidomics, since different lipid classes are responsible for important ion suppression events. We propose here an improved lipidomics method to assess local ion suppression of phospatidylcholines in tissues. Serial tissue sections were spiked with different amounts of PC(16:0 d31/18:1) using a nebulization device. Settings for standard nebulization were strictly controlled for a detection similar to when using spiked tissue homogenates. The sections were simultaneously analyzed by MALDI MSI using a Fourier transform ion cyclotron resonance analyzer. Such a spray-based approach allows taking into account the biochemical heterogeneity of the tissue for the detection of PC(16:0 d31/18:1). Thus, here we present the perspective to use this method for quantification purposes. The linear regression lines are considered as calibration curves and we calculate PC(16:0/18:1) quantification values for different ROIs. Although those values need to be validated by a using a different independent approach, the workflow offers an insight into new quantitative mass spectrometry imaging (q-MSI) methods. This approach of ion suppression monitoring of phosphocholines in tissues may be highly interesting for a large range of applications in MALDI MSI, particularly for pathology using translational science workflows.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26871868     DOI: 10.1089/omi.2015.0165

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  5 in total

Review 1.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

2.  Molecular Histology Analysis of Cryopreserved Tissue Using Peptide/Protein MALDI-TOF Imaging Mass Spectrometry (MALDI-IMS).

Authors:  Ibon Iloro; Iraide Escobés; Mikel Azkargorta; Félix Elortza
Journal:  Methods Mol Biol       Date:  2022

3.  Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry.

Authors:  Rémi Longuespée; Annika K Wefers; Elena De Vita; Aubry K Miller; David E Reuss; Wolfgang Wick; Christel Herold-Mende; Mark Kriegsmann; Peter Schirmacher; Andreas von Deimling; Stefan Pusch
Journal:  Acta Neuropathol Commun       Date:  2018-03-02       Impact factor: 7.578

4.  Validation of MALDI-MS imaging data of selected membrane lipids in murine brain with and without laser postionization by quantitative nano-HPLC-MS using laser microdissection.

Authors:  Fabian B Eiersbrock; Julian M Orthen; Jens Soltwisch
Journal:  Anal Bioanal Chem       Date:  2020-07-25       Impact factor: 4.142

5.  Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison.

Authors:  Lieke Lamont; Darya Hadavi; Brent Viehmann; Bryn Flinders; Ron M A Heeren; Rob J Vreeken; Tiffany Porta Siegel
Journal:  Anal Bioanal Chem       Date:  2021-03-26       Impact factor: 4.142

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.